Table 3: Clinical characteristics of B- and T-lineage ALL according to CD10 expression


Variable

B-lineage ALL, n=178

T-lineage ALL, n=33


 

 

CD10+
n (%)

CD10-
n (%)

p value

n(%)

CD10+
n (%)

CD10-
n (%)

p value


Sex

 

 

 

 

 

 

 

 

 Male

100(56)

80 (80)

20 (20)

0.37

25(76)

6 (24)

19 (76)

0.16

 Female

78 (44)

58 (74)

20 (26)

 

8 (24)

4 (50)

4 (50)

 

Age

 

 

 

 

 

 

 

 

1-9 years

139(78)

107(77)

32 (23)

0.74

26(79)

10(39)

16 (61)

0.05

10 years

39 (22)

31 (80)

8 (20)

 

7 (21)

0 (0)

7 (100)

 

WBC

 

 

 

 

 

 

 

 

< 50.000/ mm3

148(83)

115 (78)

33 (22)

0.90

21(64)

8 (38)

13 (62)

0.20

> 50.000/ mm3

30 (17)

23 (77)

7 (23)

 

12(36)

2 (17)

10 (83)

 

FAB

 

 

 

 

 

 

 

 

 L1

145(82)

115 (79)

30 (21)

0.23

30(91)

8 (27)

22 (72)

0.15

 L2

33 (18)

23 (70)

10 (30)

 

3 (9)

2 (67)

1 (33)

 

Risk*

 

 

 

 

 

 

 

 

 SR

94 (53)

78 (83)

16 (17)

0.07

0

0 (0)

0 (0)

 

 HR

84 (47)

60 (71)

24 (29)

 

33

10 (30)

23 (70)

 


 

*Risk Classification based on NCI criteria

Supriyadi et al.Journal of Cancer Therapeutics and Research  2012 1:20DOI : 10.7243/2049-7962-1-20